News

Arteris Inc: Strong Q3 Performance and Future Plans for Growth

Arteris Inc: Strong Q3 Performance and Future Plans for Growth

Arteris Inc: Financial Performance and Future Outlook

Arteris, Inc. (NASDAQ: AIP), a prominent provider of semiconductor system IP designed to accelerate the creation of system-on-chip (SoC), has published its financial results for the third quarter ended September 30. The company reported notable achievements, positioning it well for growth.

Remarkable Financial Highlights for Q3 2025

During the third quarter of 2025, Arteris recorded an Annual Contract Value (ACV) combined with royalties amounting to $74.9 million, marking a 24% increase year-over-year. Additionally, Remaining Performance Obligations (RPO) reached $104.7 million, demonstrating a robust increase of 34% from the previous year. This milestone represents a significant benchmark, surpassing $100 million for the first time in the company's history.

Quarterly Financial Overview

  • Revenues hit $17.4 million, reflecting an 18% rise compared to last year.
  • The operational loss stood at $8.7 million, slightly up from the operating loss of $7.9 million in the corresponding period last year.
  • Non-GAAP operating loss recorded an amount of $3.5 million, against $3.3 million from last year.
  • Net loss reported was $9.0 million, equating to $0.21 per share.
  • Positive non-GAAP free cash flow was achieved, totaling $2.5 million, which is approximately 14% of revenue.

Dynamic Business Developments

Arteris has seen significant developments in its business arena. The company has expanded its partnerships with industry leaders to further its innovation in advanced technologies such as AI and autonomous driving.

Key Business Developments

  • Altera has widened its engagement with Arteris, increasing its licenses for existing IP products.
  • AMD placed additional orders for Arteris technology, following a substantial licensing agreement earlier this year.
  • The company welcomed new automotive and industrial clients, including Dream Chip and a leading supplier of automotive technology.
  • 2V Systems engaged Arteris for its Ncore and FlexNoC interconnect solutions aimed at developing a high-performance IO Hub chiplet.
  • Collaboration with Alibaba Damo Academy has intensified, focusing on optimizing CPU core integration.
  • Joining the Ultra Accelerator Link Consortium (UALink) enhances Arteris's role in AI data processing for chiplets and SoCs.

2025 Guidance: Looking Ahead

As for the future, Arteris elaborated on its estimated guidance for the fourth quarter and full-year performance for 2025. The company anticipates its ACV plus royalties to be in the range of $74.0 to $78.0 million.

Financial Expectations

  • Forecasted revenue for Q4 2025 is projected between $18.4 to $18.8 million.
  • Non-GAAP operating loss for Q4 is expected to be in the range of $2.3 to $3.3 million.
  • Free cash flow forecasts suggest potential values between $0.2 to $3.2 million in Q4 and $2.5 to $5.5 million for the full year.

CEO's Vision for Growth

K. Charles Janac, the President and CEO of Arteris, expressed optimism regarding the company's strategic direction and growth prospects. He noted that the surge in AI adoption and the growing complexity of chiplet-based architectures are pivotal for Arteris's future potential.

Investor Engagements and Communication

Arteris's commitment to transparency is reflected in its plans to conduct a conference call to discuss its financial performance and outlook. Stakeholders are encouraged to participate.

About Arteris

Arteris, Inc. stands at the forefront of system IP technology for semiconductors, dedicated to advancing high-performance silicon components. The company focuses on network-on-chip (NoC) innovations and SoC integration automation to enhance productivity and expedite product development.

Frequently Asked Questions

1. What are the recent financial results of Arteris?

Arteris reported Q3 revenues of $17.4 million with a 24% increase in Annual Contract Value plus royalties at $74.9 million.

2. How has Arteris partnered with industry leaders?

Arteris has expanded collaborations with companies like Altera and AMD to boost its technology reach in the semiconductor industry.

3. What is the estimated guidance for Arteris in 2025?

The estimated ACV plus royalties for Arteris in 2025 is projected to be between $74.0 to $78.0 million.

4. What role does Arteris play in AI and advanced technologies?

Arteris is involved in the development of systems that support AI integration and autonomous driving technologies, enhancing its positioning in the market.

5. How can investors engage with Arteris regarding their financial outlook?

Arteris will host a conference call where investors can directly engage and discuss the company's financial performance and forward strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ABnet Touts Anthropic's AI in Corporate Evolution

Updated Category News Views 7

Changing the AI Game in Enterprise At the heart of Tel Aviv-Yafo, ABnet Communication Ltd. is spitting fire, and this ain't your average tech chatter. They're drilling right down to the marrow, stressing just how much Anthropic—kingpin of advanced AI for enterprises—is shaking up the corporate shell game. Today’s conversation leans heavily into autonomous AI, and...

Continue Reading
Matchi Debuts Protein-Packed Matcha Lattes in Cans

Updated Category News Views 3

A New Twist on Protein Beverages Today, Matchi Global LLC is rolling out something new and bold: canned protein matcha lattes. It's not just another protein shake disguised in green robes. Oh no, this is a straight-up attempt to mesh pure ceremonial-grade matcha with a full 20 grams of complete filtered milk protein. And they’re delivering it all without any of those...

Continue Reading
Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Updated Category News Views 3

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...

Continue Reading
TerraMaster 725 NAS Unveils AI-Era Storage Solutions

Updated Category News Views 3

Tech Giants and Pioneers Rejoice Strap in, because TerraMaster just waved the green flag on their brand-new 725 Series Xeon Rackmount NAS, and it's high time the data storage world got a shake-up. Picture this: we're in the throes of an AI boom, and companies have data needs that gobble up yesterday's solutions with the hunger of a black hole. Well, enter TerraMaster's...

Continue Reading
ScriptSafe Revolutionizes Pharmacy Payment & Ad Certification

Updated Category News Views 2

Pharmacy Certification Made Easy When ScriptSafe rolled out its certification service for pharmacies, it felt like the industry's straitjacket was finally coming off. We’re talking about a process that traditionally took months, cost a small fortune, and made pharmacies fill out forms like they were honing a doctoral thesis. But now, you've got ScriptSafe offering a...

Continue Reading
ViewScan Unveils New AI Solution and Enhanced Site

Updated Category News Views 3

ViewScan's Latest Step in AI-Powered Monitoring Long Island's own ViewScan just kicked up some dust in the AI-based monitoring scene. This outfit is rolling out a new release of its ViewScan Protect software, fortified with advanced analytics aimed at beefing up security and operational efficiency. Now, before you gloss over this news as just another tech update, let me...

Continue Reading
Handshake Introduces AI Skills Studio at NYSE Event

Updated Category News Views 5

Shaking Up the Job Market with AI Skills What's shaking things up this time around? Handshake's dramatic unveiling of its AI Skills Studio, that's what. While the world spins on its financial axis, Handshake's showing up with a toolkit that's not just geeky gobbledygook. They're dead set on prepping job seekers with the nitty-gritty of AI know-how hosted in a rather...

Continue Reading
GRAI's Innovative Play with Hangout FM in Streaming

Updated Category News Views 4

Reimagining Streaming: GRAI Buys Hangout FM The music streaming game has just been dealt a fresh hand. GRAI, an AI-driven music company, has snatched up Hangout FM, looking to ignite a social revolution in how we experience music. Sitting here, I'm thinking about all those playlists we've built but never truly shared. This acquisition might just change that by combining...

Continue Reading
FBI Vet Marcus Thomas Joins Re-fined Nonprofit Board

Updated Category News Views 3

Remember the days when the FBI felt like a mythical fortress of surveillance and high-tech wizardry? Today, we're seeing one of its key veterans, Marcus Thomas, take a different path—a path that's as gritty and necessary as any Wall Street hustle. He's jumping onto the board of Re-fined, a Denver nonprofit aiming to give survivors of sexual exploitation and human...

Continue Reading
Gun Violence Expo Aims for National Impact in Chicago

Updated Category News Views 4

Converging Minds at the Chicago Gun Violence Expo In a city known for its resilience amid diverse challenges, the National Gun Violence Prevention Expo is stepping into the spotlight. With all eyes on Chicago from September 24 to 26, this isn't just another event—it’s a clarion call for action. Uniting Influential Voices When you've got former NFL stars like Matt...

Continue Reading

Top 5 Most Recently Viewed Articles

Health Canada Greenlights Bylvay™ for Alagille Syndrome Relief

Updated Category News Views 132

Health Canada's Approval of Bylvay™ for Alagille Syndrome Bylvay™ is a groundbreaking medication that has recently received approval from Health Canada, becoming the first of its kind to treat both Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis. This approval is particularly significant as it offers hope to patients aged 12 months and older who...

Continue Reading
Delta Airlines Faces Turbulence Amid Legal Challenges Ahead

Updated Category News Views 270

Delta Airlines Climbs in Pre-Market Trading Delta Air Lines, Inc. (NYSE: DAL) experienced a notable 2.61% increase in pre-market trading. This rise follows the airline's recent decision to take legal action against Crowdstrike Inc. (NASDAQ: CRWD), marking significant developments for both companies. Market Performance Overview Delta Airlines' stock was quoted at $55.34,...

Continue Reading
Warner Bros Discovery Gains Favor While Fox Corp Faces Downgrade

Updated Category News Views 103

Warner Bros Discovery Receives Upgraded Rating MoffettNathanson has recently made headlines by upgrading Warner Bros Discovery Inc (NASDAQ: WBD) from a 'Neutral' to a 'Buy' rating. This significant change in outlook is driven by enhancements in the company's financial stability, impressive growth at Max, and the alleviation of various studio challenges. Positive Financial...

Continue Reading
Allarity Therapeutics Doses Second Patient in Ovarian Cancer Trial

Updated Category News Views 109

Advancing Treatment Options with Stenoparib Allarity Therapeutics, Inc. (NASDAQ: ALLR), a prominent name in the biopharmaceutical industry, has set a significant milestone by dosing its second patient in a Phase 2 clinical trial. This trial aims to explore the efficacy of stenoparib, a dual PARP and WNT pathway inhibitor, for individuals battling advanced ovarian cancer...

Continue Reading
NOTÖRIOUS Unleashes Debut EP 'Live It Up' with Heavy Sound

Updated Category News Views 222

NOTÖRIOUS Launches 'Live It Up' with a Self-Titled EP With their new single "Live It Up" and a self-titled EP that carries their name with pride, NOTÖRIOUS proves that rock is far from being dormant. The group, renowned for their vibrant energy and explosive performances, is infusing glam metal with their distinctive sound. The Spirit of Glam Metal is Alive "Tonight's...

Continue Reading